1. Home
  2. LIND vs NKTR Comparison

LIND vs NKTR Comparison

Compare LIND & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lindblad Expeditions Holdings Inc.

LIND

Lindblad Expeditions Holdings Inc.

HOLD

Current Price

$25.80

Market Cap

2.0B

ML Signal

HOLD

Logo Nektar Therapeutics

NKTR

Nektar Therapeutics

HOLD

Current Price

$69.12

Market Cap

2.2B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LIND
NKTR
Founded
1979
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Transportation Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.0B
2.2B
IPO Year
2011
1996

Fundamental Metrics

Financial Performance
Metric
LIND
NKTR
Price
$25.80
$69.12
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
7
Target Price
$22.25
$146.67
AVG Volume (30 Days)
773.1K
509.5K
Earning Date
05-05-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
5.97
N/A
EPS
0.07
N/A
Revenue
N/A
$307,711,000.00
Revenue This Year
$10.98
N/A
Revenue Next Year
$6.98
N/A
P/E Ratio
$362.21
N/A
Revenue Growth
N/A
86.00
52 Week Low
$11.37
$33.40
52 Week High
$35.00
$109.00

Technical Indicators

Market Signals
Indicator
LIND
NKTR
Relative Strength Index (RSI) 30.65 44.65
Support Level $24.79 $70.24
Resistance Level $30.00 $76.49
Average True Range (ATR) 1.26 2.88
MACD -0.64 -0.31
Stochastic Oscillator 10.99 15.34

Price Performance

Historical Comparison
LIND
NKTR

About LIND Lindblad Expeditions Holdings Inc.

Lindblad Expeditions Holdings Inc provides expedition cruising and adventure travel services. The company operates in two segments: Lindblad and Land Experiences, of which Lindblad generates the vast majority of its revenue. It offers itineraries that feature up-close encounters with wildlife, nature, history, and culture, as well as promote guest empowerment and interactivity. It operates expeditions on intimately-scaled ships and interaction between guests, crew, and the teams of scientists, naturalists, researchers, and photographers that participate in the expeditions. Lindblad operates a fleet of twelve owned expedition ships and five seasonal charter vessels under the Lindblad brand.

About NKTR Nektar Therapeutics

Nektar Therapeutics is a clinical-stage, research-based biopharmaceutical company headquartered in San Francisco, California, and incorporated in Delaware, focused on discovering and developing medicines in the field of immunotherapy. The Company directs its efforts toward creating immunomodulatory agents that selectively induce, amplify, attenuate, or prevent immune responses to achieve desired therapeutic outcomes. Its pipeline of clinical-stage and preclinical-stage immunomodulatory agents targets the treatment of autoimmune diseases, including rezpegaldesleukin, NKTR-0165, NKTR-0166, and NKTR-422, as well as cancer, including NKTR-255.

Share on Social Networks: